Sermorelin vs Tesamorelin: GHRH Analog Research Comparison
A research-based comparison of sermorelin vs tesamorelin. Tesamorelin’s half-life is ~63 minutes, far longer than sermorelin’s ~12 minutes.
Tag: GH axis
Ipamorelin vs Hexarelin: GH Secretagogue Research
Ipamorelin vs hexarelin: ipamorelin is a selective GHS-R1a agonist. Hexarelin is more potent but elevates cortisol and prolactin in research models.
CJC-1295 No DAC vs With DAC: Research Comparison
CJC-1295 No DAC vs with DAC: the DAC version extends half-life to 6-8 days via albumin binding. No DAC mimics pulsatile GH release in pituitary research.
Peptides and the Hypothalamic-Pituitary Axis
HPA axis peptide research covers GHRH analogs and GH secretagogues. Studies map how the hypothalamus and pituitary control GH pulse output in lab models.
IGF-1 Signaling: PI3K/Akt/mTOR Pathway Research
IGF-1 pathway research maps PI3K, Akt, and mTOR signaling. Studies show this cascade regulates cell growth, protein production, and survival in lab models.
IGF-1 LR3 vs MGF: Muscle Research Compared
An igf-1 lr3 vs mgf research comparison examining structure, half-life, receptor binding, and research applications of these two IGF-1 gene variants.
Sermorelin vs Ipamorelin: GH Research Compared
Compare sermorelin vs ipamorelin research: GHRH analog versus ghrelin mimetic, half-life differences, selectivity data, and combined-pathway findings.
CJC-1295 With DAC: Drug Affinity Complex GH Research
A research overview of CJC-1295 with DAC: a long-acting GHRH analog with an albumin-binding DAC and findings from animal GH pulse studies.
CJC-1295 Research: How This GHRH Analog Works in Lab Models
CJC-1295 research explained: GHRH receptor activation, GH pulse data, DAC vs No DAC half-life differences, and sourcing standards for research-grade labs.
Tesamorelin Research: GHRH Analog Mechanism Studies
Tesamorelin research explained: GHRH analog structure, pituitary receptor activation, visceral fat findings, half-life advantage, and sourcing standards.